sub:assertion {
  d:DB01511 v:identifier "DB01511" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB01511" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB01511> ;
    dv:drugbank-id "DB01511" ;
    dv:x-bindingdb <http://bio2rdf.org/bindingdb:50026858> ;
    dv:x-cas <http://bio2rdf.org/cas:2894-67-9> ;
    dv:x-chemspider <http://bio2rdf.org/chemspider:16929> ;
    dv:x-kegg <http://bio2rdf.org/kegg:D07784> ;
    dv:x-pubchemcompound <http://bio2rdf.org/pubchem.compound:17925> ;
    dv:x-pubchemsubstance <http://bio2rdf.org/pubchem.substance:46504957> ;
    dv:x-wikipedia <http://bio2rdf.org/wikipedia:Delorazepam> ;
    dct:description """Delorazepam is a benzodiazepine which, like other drugs in its class, possesses anxiolytic, skeletal muscle relaxant, hypnotic and anticonvulsant properties. It may have adverse effects such as drowsiness, and cognitive impairments such as short term memory impairment. [4]   

Delorazepam is an active metabolite of the benzodiazepine known as cloxazolam. It is a long acting benzodiazepine which makes it superior in this sense to lorazepam which is short acting. Lorazepam is also a major active metabolite of delorazepam.

In addition to be long acting, delorazepam is relatively potent, with 1 mg of delorazepam being the equivalent of 10 mg diazepam. [Wikipedia]  It has been approved for marketing in Italy."""@en ;
    dct:identifier "drugbank:DB01511" ;
    dct:title "Delorazepam"@en ;
    a dv:Drug ;
    rdfs:label "Delorazepam [drugbank:DB01511]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB01511> , <http://www.drugs.com/international/delorazepam.html> .
}